Lexicon Pharmaceuticals Inc (LXRX)
0.8634
+0.09
(+11.88%)
USD |
NASDAQ |
Nov 22, 16:00
0.8755
+0.01
(+1.40%)
After-Hours: 20:00
Lexicon Pharmaceuticals Revenue (Annual): 1.204M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.204M |
| December 31, 2022 | 0.139M |
| December 31, 2021 | 0.298M |
| December 31, 2020 | 24.00M |
| December 31, 2019 | 322.07M |
| December 31, 2018 | 63.21M |
| December 31, 2017 | 91.69M |
| December 31, 2016 | 79.26M |
| December 31, 2015 | 130.01M |
| December 31, 2014 | 22.85M |
| December 31, 2013 | 2.222M |
| December 31, 2012 | 1.089M |
| December 31, 2011 | 1.849M |
| Date | Value |
|---|---|
| December 31, 2010 | 4.908M |
| December 31, 2009 | 10.70M |
| December 31, 2008 | 32.32M |
| December 31, 2007 | 50.12M |
| December 31, 2006 | 72.80M |
| December 31, 2005 | 75.68M |
| December 31, 2004 | 61.74M |
| December 31, 2003 | 42.84M |
| December 31, 2002 | 35.20M |
| December 31, 2001 | 30.58M |
| December 31, 2000 | 14.46M |
| December 31, 1999 | 4.70M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.139M
Minimum
2022
322.07M
Maximum
2019
69.54M
Average
1.204M
Median
2023
Revenue (Annual) Benchmarks
| Viatris Inc | 15.43B |
| Halozyme Therapeutics Inc | 829.25M |
| Perspective Therapeutics Inc | -- |
| Quanterix Corp | 121.14M |
| Autonomix Medical Inc | -- |